AMLX is currently covered by 6 analysts with an average price target of $41.1. This is a potential upside of $15.08 (57.96%) from yesterday's end of day stock price of $26.02.
Our record on AMLX covers 11 analysts since 2008; 5 cover it today. Of the 97 price targets those analysts set on AMLX, 53 were reached (55%). The highest performance score on AMLX belongs to Graig Suvannavejh of Mizuho: 20.70, with 9 of 23 targets met in 257 days on average. The latest calls: Graig Suvannavejh of Mizuho raised the target to $39 from $30 with a Buy rating on 10 Nov 2026; Geoff Meacham of Citi raised the target to $39 from $26 with a Buy rating on 15 Oct 2026; Seamus Fernandez of Guggenheim raised the target to $57 from $55 with a Buy rating on 27 Aug 2026. Figures as of 18 Nov 2026.
Amylyx Pharmaceuticals's activity chart (see below) currently has 101 price targets and 102 ratings on display. The stock rating distribution of AMLX is 100% BUY.
Analysts' price targets on this stock were met 45.37% of the time, taking 174.23 days on average.
Highest price target for AMLX is $57, Lowest price target is $19, average price target is $41.1.
Most recent stock forecast was given by ANANDA GHOSH from HC WAINWRIGHT.
Currently out of the existing stock ratings of AMLX, 18 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2026
$55
$28.98 (111.38%)
2 days ago
(18-Nov-2026)
Buy Since 13-May-2025
$39
$12.98 (49.88%)
$30
11 days ago
(09-Nov-2026)
9/23 (39.13%)
$8.09 (26.17%)
257
Buy Since 16-Jun-2025
$39
$12.98 (49.88%)
$26
1 months 6 days ago
(14-Oct-2026)
6/10 (60%)
$11.35 (41.05%)
156
Buy Since 23-Jun-2025
$57
$30.98 (119.06%)
$55
2 months 25 days ago
(26-Aug-2026)
3/6 (50%)
$19.82 (53.31%)
260
Buy Since 01-Jan-2024
$52
$25.98 (99.85%)
3 months 2 days ago
(18-Aug-2026)
1/2 (50%)
$13.4 (34.72%)
960
What is AMLX (Amylyx Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on AMLX (Amylyx Pharmaceuticals)?
Which analyst has the most public recommendations on AMLX (Amylyx Pharmaceuticals)?
Which analyst is the currently most bullish on AMLX (Amylyx Pharmaceuticals)?
Which analyst is the currently most reserved on AMLX (Amylyx Pharmaceuticals)?